Stock Chart
NVCR
Type: BUY wallstreet
Strike: $23
Premium: $0.65
Expiry: Jan 15, 2027
Target: $25
Score: 100
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About NVCR - NovoCure Limited Ordinary Shares
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest …
Key Statistics
More NVCR Analysis
This NVCR stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track NVCR's price movements with trendlines, gamma walls, and key support/resistance levels.